Nanomaterials
with inherent enzyme-mimetic properties
have been
extensively studied in biosensing field, but it is still challenging
to overcome their natively weak enzyme-mimetic activity and further
promote their stabilities. In this work, a three-in-one artificial
enzyme with synergistically enhanced peroxidase-like activity and
outstanding stability is constructed by restricting Au-loaded CeO2 nanorods (NR) (1% Au:CeO2 mass ratio) inside Cu-based
metal–organic frameworks (Cu(PABA)), termed Au1/CeO2 NR@Cu(PABA). It has been demonstrated that the artificial
enzyme possesses significantly improved performance in catalytic decomposition
of H2O2, with ∼2.41 and ∼1.49
times higher activity than its individual constituents (Au1/CeO2 NR and Cu(PABA)), benefiting from the synergistic
effect and the unique restricted structure; owns strong affinities
to substrates, with separately ∼8.21- and ∼3.13-fold
lower Michaelis constants toward H2O2 and o-phenylenediamine, respectively, than horseradish peroxidase;
and exhibits desirable pH (4–12), thermal (30–80 °C),
organic solvent (N,N-dimethylformamide,
acetone, methanol, etc.), and long-term storage (30 days) stabilities,
advantaging practical applications. Taking aforementioned superior
properties of Au1/CeO2 NR@Cu(PABA), a universal
colorimetric/fluorometric dual-mode sensing platform is built and
utilized for detection of biomarkers (e.g., glucose, galactose, and
cholesterol) in biological fluids with satisfactory recoveries (90.2–108%).
This work offers new horizons in designing high-efficiency, stable,
and credible biomimetic catalysts to accelerate future advanced engineering
of nanozymes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.